Bavarian Nordic says more upgrades could be on the way

The biotech firm’s third upgrade in three weeks came hot on the heels of a recent contract with the US government. Should more orders follow, it could result in more upgrades, says Bavarian’s head of investor relations.
Photo: Philip Davali/Ekstra Bladet, Philip Davali
Photo: Philip Davali/Ekstra Bladet, Philip Davali
by marketwire, translated by daniel pedersen

Bavarian Nordic raised its expectations for the full year on Friday last week, a consequence of the vaccine firm signing a contract with the US government concerning half a million doses of monkeypox vaccine Jynneos.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading